Toral Vaidya is a Dermatology physician affiliated with Cornell University. OpenAlex indexes 22 publications with 341 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
820 2nd Ave Rm 3a
New York, NY 100174534
Telephone
212-661-3376Provider last certified this registry record 1 May 2024.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20256 payments$11,914openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year202511 payments
- ABBVIE INC.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
37%Corticosteroid13.7%Triamcinolone Acetonide100%Part D≥17 patientsalpha-Hydroxy Acid9.1%Ammonium Lactate100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
27.9%Azole Antifungal19.6%Ketoconazole100%Part D≥21 patientsNitroimidazole Antimicrobial8.2%Metronidazole100%Part D<11 patientsSensory organs
24.7%Corticosteroid24.7%Clobetasol Propionate78%Hydrocortisone22%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating Common Ingredients Contained in Dietary Acne Supplements: An Evidence-Based Review.
PubMed
2024 - Development of patient decision aids for the treatment of lentigo maligna and low-risk basal cell carcinoma
Journal of the American Academy of Dermatology
2022 - Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer
Journal of the American Academy of Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Devereux, MD
Cornell University
Thomas Walsh, MD
Cornell University
Cora Sternberg, MD
Cornell University
George Alexopoulos, MD
Cornell University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”